AngelEye Health, Inc. raises $3M under Reg D
How this compares
- Among 97 fund launches filed from TN in the same window it is larger than 44%; the TN median is $12.4M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-04-14 | D | $3M | 4 | |
| 2026-09-24 | D | $10M | 28 | +$7M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Angeleye Health on EDGAR
Earlier and related filings by the same issuer and sponsor.
People on the filing
| Christopher Rand | Executive Officer, Director |
| Alexander M. Whitmore | Director |
| Byron M. Smith | Director |
| Jack M. Slaughter | Director |
| Gerard M. Hayden, Jr. | Director |
| Emily M. Rash | Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Christopher Rand, President.
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.